Henrik Zetterberg (neurochemist)

Edit links
From Wikipedia, the free encyclopedia
Henrik Zetterberg
Born1973 (age 50–51)
Alma materUniversity of Gothenburg
Known forAlzheimer research
Scientific career
FieldsNeurochemistry
InstitutionsUniversity of Gothenburg and University College London
Doctoral advisorLars Rymo[1]
Other academic advisorsDennis J. Selkoe

Henrik Zetterberg (born 1973)[2] is a Swedish professor of neurochemistry at the University of Gothenburg, where he is the Head of the Department of Neurochemical Pathophysiology and Diagnostics.[3] He is also the leader of the Fluid biomarkers for neurodegenerative diseases group at University College London. The groups work on developing early tests for dementia.[4]

Early life and career[edit]

Zetterberg was born[2] and brought up in the Gothenburg archipelago, Sweden.[1] He completed his doctoral thesis in 2003 on the subject of the Epstein–Barr virus.[5] He performed postdoctoral research at Harvard using zebrafish as a model for alzheimer's disease.[6][1] Zetterberg has worked together with Kaj Blennow, whom he met during his PhD, on many projects including coleading the Clinical Neurochemistry Laboratory together with him.[1]

Research[edit]

His research includes the development of methods for early diagnostics for frontotemporal dementia through the use of Biomarkers,[7] In 2020, a team of scientists led by Zetterberg published results regarding a new diagnostic for Alzheimer's disease based on protein concentrations in cerebrospinal fluid, which is a colorless fluid surrounding the brain and spinal cord. The test was reported to have an accuracy of around 90% and could detect the disease about two decades before significant symptoms were present.[8]

References[edit]

  1. ^ a b c d Kirby, Tony. "Henrik Zetterberg: biomarking neurological" (PDF). thelancet.com. The Lancet. Retrieved 7 May 2021.
  2. ^ a b "Henrik Zetterberg - Sveriges Unga Akademi". www.sverigesungaakademi.se. Sveriges Unga Akademi. Retrieved 6 May 2021.
  3. ^ "Henrik Zetterberg | Göteborgs universitet". www.gu.se (in Swedish). University of Gothenburg. Retrieved 6 May 2021.
  4. ^ Institute, UK DRI: UK Dementia Research (6 May 2021). "Meet the team: Henrik Zetterberg". ukdri.ac.uk. UK Dementia Research Institute. Retrieved 7 May 2021.
  5. ^ Zetterberg, Henrik (2003). Transcriptional regulation of the Epstein-Barr virus nuclear antigen 1 gene in latent and lytic stages of infection. ISBN 91-628-5749-5.
  6. ^ Lundgren, Eva (2013-06-17). "Profilen: Henrik Zetterberg – Med nyfiket sinne". GU Journalen. No. 4 2013. University of Gothenburg.
  7. ^ "Han för demensforskningen framåt på flera sätt". www.hjarnfonden.se (in Swedish). Hjärnfonden. 19 September 2018. Retrieved 6 May 2021.
  8. ^ Fredholm, Lotta (9 December 2020). "Nytt slags blodtest hittar alzheimer tidigt". fof.se (in Swedish). Forskning & Framsteg. Retrieved 6 May 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Henrik_Zetterberg_(neurochemist)&oldid=1178359545"